1,607 Shares in McKesson Co. (NYSE:MCK) Acquired by Lbp Am Sa

LBP AM SA purchased a new position in McKesson Co. (NYSE:MCK - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 1,607 shares of the company's stock, valued at approximately $916,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. purchased a new position in shares of McKesson during the third quarter valued at approximately $29,000. RPg Family Wealth Advisory LLC purchased a new position in shares of McKesson during the third quarter valued at approximately $31,000. Synergy Asset Management LLC purchased a new position in shares of McKesson during the fourth quarter valued at approximately $32,000. Crews Bank & Trust purchased a new stake in shares of McKesson in the fourth quarter valued at approximately $33,000. Finally, Creative Capital Management Investments LLC purchased a new stake in shares of McKesson in the fourth quarter valued at approximately $44,000. Hedge funds and other institutional investors own 85.07% of the company's stock.

Wall Street Analyst Weigh In

MCK has been the subject of a number of research reports. Evercore ISI boosted their price target on McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a report on Thursday, February 6th. Wells Fargo & Company boosted their price target on McKesson from $641.00 to $691.00 and gave the company an "equal weight" rating in a report on Friday, March 14th. Morgan Stanley boosted their price target on McKesson from $612.00 to $642.00 and gave the company an "overweight" rating in a report on Tuesday, December 17th. Bank of America lowered their price target on McKesson from $680.00 to $650.00 and set a "buy" rating for the company in a report on Monday, January 6th. Finally, Mizuho started coverage on shares of McKesson in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $630.00 price objective for the company. Two investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $649.36.

Remove Ads

McKesson Trading Up 0.4 %

Shares of MCK stock traded up $2.67 during trading hours on Thursday, reaching $666.46. 720,083 shares of the company's stock were exchanged, compared to its average volume of 792,544. The company has a market cap of $83.52 billion, a price-to-earnings ratio of 30.52, a P/E/G ratio of 1.29 and a beta of 0.52. McKesson Co. has a fifty-two week low of $464.42 and a fifty-two week high of $669.82. The stock's 50 day moving average is $613.05 and its 200-day moving average is $573.00.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. Equities analysts anticipate that McKesson Co. will post 32.77 EPS for the current year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be issued a $0.71 dividend. The ex-dividend date of this dividend is Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a yield of 0.43%. McKesson's payout ratio is 13.00%.

Insider Buying and Selling at McKesson

In other news, EVP Leann B. Smith sold 188 shares of the firm's stock in a transaction that occurred on Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total transaction of $114,602.92. Following the completion of the sale, the executive vice president now owns 1,051 shares in the company, valued at $640,679.09. This trade represents a 15.17 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Brian S. Tyler sold 8,961 shares of the firm's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $600.66, for a total transaction of $5,382,514.26. Following the sale, the chief executive officer now owns 69,625 shares of the company's stock, valued at $41,820,952.50. This represents a 11.40 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 18,689 shares of company stock worth $11,187,351. Insiders own 0.11% of the company's stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.